http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011084479-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3f061c97b77568222b5ae5163b6eafee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc0061c5c96ba67317f955ab900a6ad1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e891b0a631e9cbed63e9632a999d7ebc |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-046 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10 |
| filingDate | 2010-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b17d8dadaa705da2b33072998e2ae1f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fcf158fa6a0da51bd1928ca448676e7 |
| publicationDate | 2011-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2011084479-A1 |
| titleOfInvention | Substance p and analogs thereof as adjuvant therapy for adoptive cellular immunotherapy |
| abstract | Provided herein are analogs of substance P (the peptide) use for increasing, for example, the medical effectiveness of immunotherapies for diseases like cancer, viral infection, bacterial infection, genetic diseases, autoimmune diseases and other immune -related diseases and syndromes. The analogs are relevant to both in vivo, ex vivo, or in vitro use of the peptide as an adjuvant to commonly utilized adoptive cellular immunotherapies (ACI) or newly emerging combinations of ACI and other compatible therapies for these diseases. Further provided are methods relating to the use of the peptide at various stages of ACI protocols depending on the target disease and ACI protocol envisioned. |
| priorityDate | 2009-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 211.